Odne Receives 5.5 Million Dollars for Market Launch in the USA

Dübendorf ZH – Odne has raised 5.5 million dollars in a Series A1 financing round. The spin-off from the Swiss Federal Institutes of Technology in Zurich and Lausanne intends to use the funds to finance the market launch of its innovative therapy for preserving tooth roots in the USA.

Odne can finance its upcoming market launch in the USA with additional capital: The dental start-up from Dübendorf has received 5.5 million dollars in a Series A1 financing round, according to a press release.

With its innovative therapy for preserving the tooth root, the spin-off from the two Swiss Federal Institutes of Technology in Zurich and Lausanne aims to change endodontics, the treatment of the inside of the tooth. It is performed with three new medical devices that enable minimally invasive cleaning of the root canal and light-curing sealing. Last year, Odne received approval from the US Food & Drug Administration for its laser-based dental curing device Odne Cure and its novel filling material Odne Fill

The financing round was led by dental health-focused New York venture capital firm Revere Partners and Liechtenstein-based N&V Capital. The expansion was also supported by renowned funds, including the North American Dental Innovation Alliance. It had already invested in Odne for the fifth time in January. Zürcher Kantonalbank is also part of the investor group.

"With more than 15 million root canal treatments per year, the USA is the largest market worldwide and our most important target," Odne CEO and co-founder Dr. Andreas Schmocker is quoted as saying. "We are currently running a Priority Access program to anchor the use of our products with selected US opinion leaders." In addition, the three new devices required for this treatment will be presented to the endodontic community at the annual meeting of the American Association of Endodontists in Los Angeles in April. ce/mm

View full article